Phytotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Authors:
- 1 June 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 179 (6) , 2119-2125
Abstract
We examined the available data from clinical trials for certain botanicals used for lower urinary tract symptoms secondary to benign prostatic hyperplasia, including Serenoa repens (saw palmetto), Pygeum africanum (African plum), Secale cereale (rye pollen) and Hypoxis rooperi (South African star grass). MEDLINE and The Cochrane Library searches were done in June 2007 using the terms benign prostatic hyperplasia, lower urinary tract symptoms, phytotherapy, saw palmetto, Serenoa, Permixon, Pygeum africanum, Tadenan, Cernilton, Cernitin and Hypoxis. Search results were assessed for relevance and the inclusion of placebo controlled trials. Two systematic reviews and 3 clinical trials were examined in the evaluation of Serenoa repens. Data from the systematic reviews showed an improvement in flow rates and symptoms. The results of 1 clinical trial were equivocal and the remaining 2 trials clearly showed equivalence to placebo. Systematic reviews were used in the evaluation of P. africanum, Secale cereale and Hypoxis rooperi. P. africanum and H. rooperi showed an improvement in flow rates and symptoms compared to placebo, while S. cereale showed an improvement in symptoms but not flow rates compared to placebo. Most clinical trials of investigating the efficacy of botanicals suffer from well documented methodological flaws. Saw palmetto has been clearly shown as comparable to placebo in a trial of sound methodology. While preliminary results appear promising, to our knowledge the remaining botanicals have yet to be evaluated in a trial of similar quality.Keywords
This publication has 32 references indexed in Scilit:
- Saw palmetto is an indirectly acting sympathomimetic in the rat-isolated prostate glandThe Prostate, 2005
- SERENOA REPENS TREATMENT MODIFIES BAX/BCL-2 INDEX EXPRESSION AND CASPASE-3 ACTIVITY IN PROSTATIC TISSUE FROM PATIENTS WITH BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 2005
- IS THERE A SCIENTIFIC BASIS FOR THE THERAPEUTIC EFFECTS OF SERENOA REPENS IN BENIGN PROSTATIC HYPERPLASIA? MECHANISMS OF ACTIONJournal of Urology, 2004
- Effect of permixon on human prostate cell growth: Lack of apoptotic actionThe Prostate, 2004
- Do saw palmetto extracts block human?1-adrenoceptor subtypes in vivo?The Prostate, 2001
- Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract ofSerenoa repens (LSESr, Permixon ) in benign prostatic hyperplasiaThe Prostate, 2000
- Phytotherapeutic agents in the treatment of lower urinary tract symptoms: a demographic analysis of awareness and use at the University of ChicagoUrology, 1999
- Saw palmetto extracts potently and noncompetitively inhibit human ?1-adrenoceptors in vitroThe Prostate, 1999
- Effects of the Sabal serrulata extract IDS 89 and its subfractions on 5α-reductase activity in human benign prostatic hyperplasiaThe Prostate, 1996
- Comparison of finasteride (proscar®), a 5α reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5α reductase inhibitionThe Prostate, 1993